---

title: Beta Agonist Therapy and Lactic Acidosis in Asthma
collection:
  - Pulmonology
  - Pharmacology
  - Toxicology
tags:

---

# Beta Agonist Therapy and Lactic Acidosis in Asthma

**Is the rise in lactate expected following beta-agonist therapy? Is it significant?**

**Main points**

-   Inhaled and IV beta-agonists can contribute to lactic acidosis.
-   Studies have reported lactate levels &gt;10 mmol/L. \[[Claret, 2012](http://www.ncbi.nlm.nih.gov/pubmed/?term=21802882); [Creagh-Brown, 2008](http://www.ncbi.nlm.nih.gov/pubmed/?term=18410827); [Maury, 1997](http://www.ncbi.nlm.nih.gov/pubmed/?term=9187208)\]
-   Asthmatics noted to have an elevated lactate level following beta-agonist therapy should have a thorough assessment for evidence of true tissue hypoperfusion before lactic acidosis is attributed entirely to beta-agonist therapy. 
-   While the use of continuous nebulized beta-agonist therapy is supported by [NIH's EPR-3](http://www.nhlbi.nih.gov/guidelines/asthma/), patients requiring continuous nebulizers for more than a few hours should have a lactate checked. If a high lactate is found, clinicians should consider whether the rising lactate may be contributing to their patient’s respiratory distress and consider transitioning the patient to less frequent nebulized therapy.

**Click [here](http://academiclifeinem.com/lactic-acidosis-beta-agonist-therapy-asthma/) for full ALiEM original post**

## Causes of lactic acidosis in asthma

A simple respiratory alkalosis is the most common acid-base disorder in acute asthma.\[[Mountain, 1990](http://www.ncbi.nlm.nih.gov/pubmed/?term=2118447)\] However, lactic acidosis is frequently identified especially in cases of severe asthma.\[[Roncoroni, 1976](http://www.ncbi.nlm.nih.gov/pubmed/?term=778959); [Appel, 1983](http://www.ncbi.nlm.nih.gov/pubmed/?term=6414303); [Raimondi, 2013](http://www.ncbi.nlm.nih.gov/pubmed/?term=23947392)\] 

Possible causes of lactic acidosis in asthma include:

-   Tissue hypoxia due to hypoxemia and the decrease in venous return caused by elevated intrinsic PEEP
-   Relative hepatic ischemia and impaired lactate clearance due to venous congestion
-   Increased respiratory muscle work against constricted upper airways
-   Beta-agonist therapy 

## Beta-agonists role in elevated lactate

Causes of lactic acidosis can be organized into two categories: \[[Luft, 2001](http://www.ncbi.nlm.nih.gov/pubmed/?term=11251027), [Anderson, 2013](http://www.ncbi.nlm.nih.gov/pubmed/?term=24079682)\]

-   **Type A:** Secondary to tissue hypoxia: shock, cardiac arrest
-   **Type B:** Lactic acidosis without hypoxia. This can occur through several mechanisms.

  1. Impaired pyruvate dehydrogenase activity (e.g. thiamine deficiency)
  2. Increased production by neoplastic cells
  3. Medication-induced mitochondrial dysfunction (e.g. antiretroviral therapy, linezolid, propofol)
  4. Impaired conversion of lactate to glucose (e.g. hepatic dysfunction)

Lactic acidosis caused by β-agonist therapy is a **type B lactic acidosis**. The exact mechanism for the rise in lactate levels seen with beta-agonist therapy is unclear, but stimulation of beta-receptors causes a variety of metabolic effects which may increase lactate production including: \[[Haffner, 1992](http://www.ncbi.nlm.nih.gov/pubmed/?term=1353501)\]

-   Increased glycogenolysis and glycolysis
-   Increased lipolysis leading to a rise in fatty acids levels which can inhibit conversion of pyruvate to acetyl-CoA

## Beta-agonists-induced lactic acidosis

Two small prospective studies have addressed this issue:

-   [Rodrigo et al. Emerg Med J 2005](http://www.ncbi.nlm.nih.gov/pubmed/?term=15911945)
    -   Enrolled 18 patients with acute severe asthma treated with albuterol 0.4 mg via inhaler every 10 minutes for 2 hours.
    -   Lactate levels were drawn at baseline and following treatment**. **
    -   At baseline, all patients had a lactate level &lt;2.2 mmol/L.
    -   Following treatment, the mean plasma lactate 2.9 mmol/L (significantly higher than baseline) and 4 patients had a lactate of ≥4 mmol/L.
-   [Rabbat et al. Int Care Med 1998](http://www.ncbi.nlm.nih.gov/pubmed/?term=9609407)
    -   Enrolled 29 patients admitted to an ICU with acute severe asthma.
    -   All patients received protocolized asthma care including frequent salbutamol 10 mg nebulizers and IV salbutamol 1 mg/hr. 
    -   On admission to the ICU, the mean arterial lactate was 3.11 mmol/L (range 1.1-10.4)
    -   Six hours following admission, arterial lactate levels increased in all patients to a mean of 7.4 mmol/L (2.6-16). The average lactate rise was 4.6 mmol/L. 
    -   An elevated lactate was not found to have any prognostic significance.

Multiple case reports have described a rise in lactate following either inhaled or IV beta-agonist therapy for acute asthma.\[[Claret, 2012](http://www.ncbi.nlm.nih.gov/pubmed/?term=21802882); [Creagh-Brown, 2008](http://www.ncbi.nlm.nih.gov/pubmed/?term=18410827); [Maury, 1997](http://www.ncbi.nlm.nih.gov/pubmed/?term=9187208)\] Importantly, several case reports have described beta-agonist therapy paradoxically worsening an asthmatic’s clinical course as they struggle to compensate for the rising lactic acidosis.\[[Maury, 1997](http://www.ncbi.nlm.nih.gov/pubmed/?term=9187208); [Dodda, 2012](http://www.ncbi.nlm.nih.gov/pubmed/?term=22613097); [Prakash, 2002](http://www.ncbi.nlm.nih.gov/pubmed/?term=12068341)\]

## References

-   [Prakash S, Mehta S. Lactic acidosis in asthma: report of two cases and review of the literature. Can Respir J. May-Jun 2002;9(3):203-208.](http://www.ncbi.nlm.nih.gov/pubmed/?term=12068341)
-   [Rabbat A, Laaban JP, Boussairi A, Rochemaure J. Hyperlactatemia during acute severe asthma. Intensive Care Med. Apr 1998;24(4):304-312.](http://www.ncbi.nlm.nih.gov/pubmed/?term=9609407)
-   [Claret PG, Bobbia X, Boutin C, Rougier M, de la Coussaye JE. Lactic acidosis as a complication of beta-adrenergic aerosols. Am J Emerg Med. Sep 2012;30(7):1319 e1315-1316.](http://www.ncbi.nlm.nih.gov/pubmed/?term=21802882)
-   [Raimondi GA, Gonzalez S, Zaltsman J, Menga G, Adrogue HJ. Acid-base patterns in acute severe asthma. J Asthma. Dec 2013;50(10):1062-1068.](http://www.ncbi.nlm.nih.gov/pubmed/?term=23947392)
-   [Appel D, Rubenstein R, Schrager K, Williams MH, Jr. Lactic acidosis in severe asthma. Am J Med. Oct 1983;75(4):580-584.](http://www.ncbi.nlm.nih.gov/pubmed/?term=6414303)
-   [Maury E, Ioos V, Lepecq B, Guidet B, Offenstadt G. A paradoxical effect of bronchodilators. Chest. Jun 1997;111(6):1766-1767.](http://www.ncbi.nlm.nih.gov/pubmed/?term=9187208)
-   [Luft FC. Lactic acidosis update for critical care clinicians. J Am Soc Nephrol. Feb 2001;12 Suppl 17:S15-19.](http://www.ncbi.nlm.nih.gov/pubmed/?term=11251027)
-   [Creagh-Brown BC, Ball J. An under-recognized complication of treatment of acute severe asthma. Am J Emerg Med. May 2008;26(4):514 e511-513.](http://www.ncbi.nlm.nih.gov/pubmed/?term=18410827)
-   [Mountain RD, Heffner JE, Brackett NC, Jr, Sahn SA. Acid-base disturbances in acute asthma. Chest. Sep 1990;98(3):651-655.](http://www.ncbi.nlm.nih.gov/pubmed/?term=2118447)
-   [Rodrigo GJ, Rodrigo C. Elevated plasma lactate level associated with high dose inhaled albuterol therapy in acute severe asthma. Emerg Med J. Jun 2005;22(6):404-408.](http://www.ncbi.nlm.nih.gov/pubmed/?term=15911945)
-   [Roncoroni AJ, Adrougue HJ, De Obrutsky CW, Marchisio ML, Herrera MR. Metabolic acidosis in status asthmaticus. Respiration. 1976;33(2):85-94](http://www.ncbi.nlm.nih.gov/pubmed/?term=778959)
-   [Andersen LW, Mackenhauer J, Roberts JC, Berg KM, Cocchi MN, Donnino MW. Etiology and therapeutic approach to elevated lactate levels. Mayo Clin Proc. Oct 2013;88(10):1127-1140.](http://www.ncbi.nlm.nih.gov/pubmed/?term=24079682)
-   [Haffner CA, Kendall MJ. Metabolic effects of beta 2-agonists. J Clin Pharm Ther. Jun 1992;17(3):155-164.](http://www.ncbi.nlm.nih.gov/pubmed/?term=1353501)
-   [Dodda VR, Spiro P. Can albuterol be blamed for lactic acidosis? Respir Care. Dec 2012;57(12):2115-2118.](http://www.ncbi.nlm.nih.gov/pubmed/?term=22613097)
